 | Up a level |
Sinner, Friedrich 
ORCID: 0000-0003-0524-8833, Pinter, Matthias ORCID: 0000-0002-7260-532X, Scheiner, Bernhard ORCID: 0000-0002-4904-5133, Ettrich, Thomas Jens, Sturm, Niklas ORCID: 0000-0001-9219-0099, Gonzalez-Carmona, Maria A., Waidmann, Oliver, Finkelmeier, Fabian ORCID: 0000-0001-8559-9910, Himmelsbach, Vera, De Toni, Enrico N., Ben Khaled, Najib, Mohr, Raphael ORCID: 0000-0003-2403-4275, Fruendt, Thorben Wilhelm, Kuetting, Fabian, van Boemmel, Florian, Lieb, Sabine, Krug, Sebastian ORCID: 0000-0003-1672-7995, Bettinger, Dominik ORCID: 0000-0002-8782-8729, Schultheiss, Michael, Jochheim, Leonie S., Best, Jan, Mueller, Christian ORCID: 0000-0002-6881-1817, Keitel, Verena and Venerito, Marino ORCID: 0000-0001-8581-0974
(2022).
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.
Cancers, 14 (23).
BASEL:
MDPI.
ISSN 2072-6694